Achieve Life Sciences, Inc.
General ticker "ACHV" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $113.4M (TTM average)
Achieve Life Sciences, Inc. follows the US Stock Market performance with the rate: 46.0%.
Estimated limits based on current volatility of 3.3%: low 5.46$, high 5.83$
Factors to consider:
- Total employees count: 25 (+13.6%) as of 2024
- Top business risk factors: Insufficient funding, Supply chain disruptions, Regulatory and compliance, Dependence on key products, Labor/talent shortage/retention
- Current price 30.6% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.33$, 6.69$]
- 2025-12-31 to 2026-12-31 estimated range: [1.48$, 4.46$]
Financial Metrics affecting the ACHV estimates:
- Positive: with PPE of -3.0 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -24.83 <= 0.04
- Negative: negative Industry operating cash flow (median)
- Positive: 42.53 < Shareholder equity ratio, % of 54.10 <= 64.17
- Negative: negative Net income
Short-term ACHV quotes
Long-term ACHV plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $42.35MM | $27.25MM | $39.07MM |
| Operating Income | $-42.35MM | $-27.25MM | $-39.07MM |
| Non-Operating Income | $0.00MM | $-2.56MM | $-0.76MM |
| Interest Expense | $1.79MM | $2.85MM | $2.18MM |
| R&D Expense | $30.08MM | $15.81MM | $22.82MM |
| Income(Loss) | $-42.35MM | $-29.82MM | $-39.83MM |
| Profit(Loss)* | $-42.35MM | $-29.82MM | $-39.83MM |
| Stockholders Equity | $8.30MM | $-1.45MM | $20.90MM |
| Assets | $29.97MM | $19.37MM | $38.63MM |
| Operating Cash Flow | $-37.55MM | $-24.48MM | $-29.77MM |
| Capital expenditure | $0.00MM | $0.02MM | $0.00MM |
| Investing Cash Flow | $0.00MM | $-0.02MM | $-21.58MM |
| Financing Cash Flow | $19.30MM | $15.28MM | $48.53MM |
| Earnings Per Share** | $-4.00 | $-1.50 | $-1.24 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.